Spyre Therapeutics reposted this
We're #hiring a new Senior Scientist, Translational Science in United States. Apply today or share this post with your network.
Skip to main content
Spyre Therapeutics reposted this
We're #hiring a new Senior Scientist, Translational Science in United States. Apply today or share this post with your network.
To view or add a comment, sign in
We are excited to share the appointment of Sheldon Sloan, M.D., M. Bioethics, as Chief Medical Officer of Spyre. Dr. Sloan has over 25 years of experience in both large pharmaceutical and small biotech companies and an extensive track record of program leadership in the field of inflammation and immunology. We are grateful to have Dr. Sloan on board as we continue our efforts to advance each of our programs into the clinic and initiate Phase 2 studies in 2025. Please join us in welcoming Dr. Sloan to Spyre! Read the full news here: https://lnkd.in/gbV4h6FP #IBD #BioTech
To view or add a comment, sign in
Today, Spyre is attending the Stifel 2024 Virtual Immunology and Inflammation Summit. Spyre management will participate in a virtual fireside chat and investor meetings to discuss upcoming milestones and our progress in advancing treatment for those living with IBD. To watch a replay of the webcast, head to ir.spyre.com. #IBD
To view or add a comment, sign in
Today, we announced our second quarter financial results and provided a corporate update. We are excited to have begun our first clinical study for SPY001 and progressed towards first-in-human initiations for SPY002 and SPY003. We look forward to upcoming critical milestones to prove the potential of our portfolio to benefit those living with IBD. See our latest news release for additional details: https://lnkd.in/g6NygkgN #IBD #antibody
To view or add a comment, sign in
8,000 followers
Create your free account or sign in to continue your search
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.
New to LinkedIn? Join now
or
By clicking Continue to join or sign in, you agree to LinkedIn’s User Agreement, Privacy Policy, and Cookie Policy.